Cancer drug prices slashed: 679 brands see cuts exceeding 50%, consumers to save Rs 3,540 crore
Patients purchasing cancer medicines are set to receive significant financial relief following the implementation of revised maximum retail prices (MRPs) for 1,364 anti-cancer formulations from Monday. The price revisions are expected to generate annual savings of approximately Rs 3,540.38 crore for consumers, according to an official announcement. The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has introduced… Continue reading "Cancer drug prices slashed: 679 brands see cuts exceeding 50%, consumers to save Rs 3,540 crore"